Definitive Contract W91YTZ23C0013
Award Date
10/1/23
Potential Completion Date
3/31/25
Potential Value
$1.7M
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Roche Diagnostics Corporation
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fort Liberty, NC 28310, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price delivery order contract awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at $2,187,755.49, is for core laboratory chemistry testing services to be provided to the DHA during fiscal year 2025. The contract does not have a set-aside designation. Roche Diagnostics has a history of providing...
This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for in vitro diagnostic testing services. The contract, which is a Blanket Purchase Agreement (BPA) call valued at $741,441.86, was awarded by the Defense Health Agency (DHA) with a completion date of September 5, 2020. The contract has a firm fixed price pricing type and does not have a set-aside designation. Roche Diagnostics is a foreign-owned, for-profit manufacturer of in vitro...
This is a delivery order awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, laboratory instruments, and associated medical products and services. The $615,563.49 firm fixed-price contract is for the provision of Chemistry Analyzer CPT equipment and services. It was awarded under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration (GSA) schedule contract, which allows federal...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostic products and medical laboratory equipment. The $1,259,609.08 contract is for the delivery of cost-per-reportable chemistry analyzers to be used at Langley Air Force Base in Virginia. The contract is not designated as a set-aside. Roche Diagnostics holds several significant Indefinite Delivery Vehicles and Blanket Purchase...
This is a delivery order contract awarded by the Defense Health Agency (DHA), a defense agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and associated products and services. The $341,575.26 firm-fixed-price contract provides reagents under the Critical Analyzers, Laboratory GSA Schedule contract (FSS-66-III). The contract has an ultimate completion date of March 31, 2025. Roche Diagnostics has a history of providing medical equipment,...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $1,568,370.05, is for the provision of chemistry and immunodiagnostics reagents, with a period of performance through September 30, 2025. The contract is not set-aside and was awarded under the General...
This is a firm fixed-price delivery order awarded by the Defense Health Agency to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics and laboratory instruments. The contract is for the provision of COBAS 6000 chemical analyzers, reagents, and test kits, with a ceiling value of $137,077. The contract has an ultimate completion date of September 30, 2026. Roche Diagnostics has been awarded multiple federal contracts and IDVs to supply medical equipment, reagents, and services to...
The Defense Health Agency (DHA) awarded a firm fixed-price purchase order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the supply of clinical chemistry and immunoassay reagents and analyzers. The $3,890,450.79 contract has an ultimate completion date of September 30, 2027 and was not set aside for any specific business type. This award was made in response to a sources sought notice issued by Tripler Army Medical Center in Hawaii seeking to procure Abbott...
This is a $787,038.78 firm fixed-price delivery order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical products. The contract, which has no set-aside designation, provides for the delivery of Roche's medical diagnostic technologies, including laboratory equipment, testing systems, reagents, and clinical testing services, to support...
This is a firm fixed-price delivery order awarded by the Defense Health Agency to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, laboratory instruments, and medical products. The $160,359.59 contract is for ROCHE CHEMICAL ANALYZER COVERAGE and is placed under Roche's General Services Administration (GSA) Multiple Award Schedule (MAS) contract. The contract does not have a set-aside designation, indicating Roche competed openly for this award. The...